A hitchhiker’s guide to cerebrospinal fluid biomarkers for neuro-oncologyCécile Riviere-Cazaux, Terry C. Burns, Jeffrey Zuccato et al.|Neuro-Oncology|2024Cited by 15
<i>In Vivo</i> Efficacy of Tesevatinib in <i>EGFR</i> -Amplified Patient-Derived Xenograft Glioblastoma Models May Be Limited by Tissue Binding and Compensatory SignalingSani H. Kizilbash, Jann N. Sarkaria|Molecular Cancer Therapeutics|2021Cited by 13